Condition: Cardiac Valve Disease · Sponsor: Konkuk University Medical Center
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
This description comes directly from the study's public registry record.
Tae-Yop KIm, MD PhD · +82-10-8811-6942 · taeyop@gmail.com
Always discuss trial participation with your own doctor first.
| Konkuk University Medical Center | Seoul, Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06144125